Clinical Trial Update: Spectrum of Peripheral and Autonomic Neuropathies in Patients With aTTRwt Amyloidosis and Response to Patisiran Therapy [EARLY_Phase 1]

View source ↗

Summary

An early-phase clinical trial update describing peripheral and autonomic neuropathies in wild-type transthyretin amyloidosis and response to patisiran therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transthyretin Amyloidosis
• Wild-type Transthyretin Amyloidosis
• Wild-type Transthyretin Cardiac Amyloidosis

Drugs mentioned

• Patisiran (patisiran)

Snippet

Sponsor: Austin Neuromuscular Center | Conditions: Polyneuropathies, Wild Type ATTR Amyloidosis | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING